 |
PDBsum entry 2itk
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Isomerase/isomerase inhibitor
|
PDB id
|
|
|
|
2itk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structural basis for high-Affinity peptide inhibition of human pin1.
|
 |
|
Authors
|
 |
Y.Zhang,
S.Daum,
D.Wildemann,
X.Z.Zhou,
M.A.Verdecia,
M.E.Bowman,
C.Lücke,
T.Hunter,
K.P.Lu,
G.Fischer,
J.P.Noel.
|
 |
|
Ref.
|
 |
Acs Chem Biol, 2007,
2,
320-328.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Human Pin1 is a key regulator of cell-cycle progression and plays
growth-promoting roles in human cancers. High-affinity inhibitors of Pin1 may
provide a unique opportunity for disrupting oncogenic pathways. Here we report
two high-resolution X-ray crystal structures of human Pin1 bound to non-natural
peptide inhibitors. The structures of the bound high-affinity peptides identify
a type-I beta-turn conformation for Pin1 prolyl peptide isomerase domain-peptide
binding and an extensive molecular interface for high-affinity recognition.
Moreover, these structures suggest chemical elements that may further improve
the affinity and pharmacological properties of future peptide-based Pin
inhibitors. Finally, an intramolecular hydrogen bond observed in both peptide
complexes mimics the cyclic conformation of FK506 and rapamycin. Both FK506 and
rapamycin are clinically important inhibitors of other peptidyl-prolyl cis-trans
isomerases. This comparative discovery suggests that a cyclic peptide polyketide
bridge, like that found in FK506 and rapamycin or a similar linkage, may
significantly improve the binding affinity of structure-based Pin1 inhibitors.
|
 |
|
|
|
|
 |